Matthias Englbrecht

Friedrich-Alexander-Universität Erlangen-Nürnberg — Germany

Medicine · Health Sciences

43h-index5.3kcitations173works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(105), Spondyloarthritis Studies and Treatments(50), Autoimmune and Inflammatory Disorders Research(30), Bone and Joint Diseases(26), Systemic Lupus Erythematosus Research(25)

Publications173 total

Wiederanstieg der Januskinaseinhibitor-Neuverordnungen
Zeitschrift für Rheumatologie·2025Open Access
Discordance between patient and physician reported global disease activity in PsA is associated with mental health—a cross-sectional analysis
Rheumatology International·2025· 1 citedOpen Access
Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review
Frontiers in Medicine·2025· 2 citedOpen Access
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study
The Lancet Rheumatology·2025· 6 citedOpen Access
RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings
Rheumatology International·2025Open Access
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis – a retrospective analysis from the RHADAR database
Rheumatology International·2025· 3 cited
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study
Frontiers in Immunology·2024· 3 citedOpen Access
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network
Rheumatology International·2024· 4 citedOpen Access
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial
Journal of Medical Internet Research·2024· 15 citedOpen Access
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database
Frontiers in Immunology·2024· 8 citedOpen Access
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial (Preprint)
2023Open Access
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
Patient·2023· 7 citedOpen Access
POS0377 ACCURACY OF AN AI-BASED SYMPTOM CHECKER AND AN ONLINE SELF-REFERRAL TOOL IN RHEUMATOLOGY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL
Annals of the Rheumatic Diseases·2023· 2 citedOpen Access
Clinical Application of Ultrahigh-Field-Strength Wrist MRI: A Multireader 3-T and 7-T Comparison Study
Radiology·2023· 19 cited
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance
RMD Open·2022· 15 citedOpen Access
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis
Rheumatology International·2022· 7 cited
Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis
Scandinavian Journal of Rheumatology·2022· 2 citedOpen Access
Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
Lara D. Veeken·2022· 17 citedOpen Access
[SARS-CoV-2, influenza and norovirus infection : A direct epidemiologic comparison].
PubMed·2022· 2 citedOpen Access
Transformations of Stabilizer States in Quantum Networks
arXiv (Cornell University)·2022Open Access
page 1 of 9Next →

Frequent Co-authors

Georg Schett(48), Jürgen Rech(28), Axel J. Hueber(19), Arnd Kleyer(17), Stephanie Finzel(15), Klaus Engelke(13), David Simón(12), Judith Haschka(11), Bernhard Manger(11), Roland Kocijan(8), Elizabeth Araújo(7), Stefan Kleinert(6), Camille P. Figueiredo(6), Michael Sticherling(6), Rieke Alten(5), Francesca Faustini(5), Sebastian Kraus(5), Laure Gossec(4), Martin Fleck(4), Karin Manger(4)